Biomarkers for PD How can we approach complexity?

被引：2
作者：
Berg, Daniela [1 ]
Bandmann, Oliver [2 ]
机构：
[1] Univ Tubingen, Dept Neurodegenerat, Tubingen, Germany
[2] Univ Sheffield, Sheffield Inst Translat Neurosci SITraN, Sheffield, S Yorkshire, England
来源：
NEUROLOGY | 2013年 / 80卷 / 07期
关键词：
PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; RISK; MUTATION;
D O I：
10.1212/WNL.0b013e3182825184
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：608 / 609
页数：2
相关论文
共 50 条
  • [21] How Can We Favorably Modulate Serum Uric Acid?
    Antoniazzi, Luiza
    Dias, Lais Ferreira
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2021, 117 (04) : 676 - 677
  • [22] How Can We Improve on MRD Assessment by Flow Cytometry?
    Freeman, Sylvie D.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S49 - S50
  • [23] How Can We Communicate About Vaccines With Adolescents and Their Parents?
    Benin, Andrea L.
    Wu, Ann C.
    Holmboe, Eric S.
    Shapiro, Eugene D.
    Anyan, Walter
    CLINICAL PEDIATRICS, 2010, 49 (04) : 373 - 380
  • [24] Comorbid depression and diabetes - How can we improve adherence?
    Iglay, Kristy
    Radican, Larry
    Rajpathak, Swapnil
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (07) : 1077 - 1078
  • [25] NT-proBNP: Can We Better Utilize Biomarkers in Patients With Diabetes?
    Cavender, Matthew A.
    Scirica, Benjamin M.
    DIABETES CARE, 2020, 43 (12) : 2904 - 2905
  • [26] How can a Bayesian approach inform neuroscience?
    O'Reilly, Jill X.
    Jbabdi, Saad
    Behrens, Timothy E. J.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2012, 35 (07) : 1169 - 1179
  • [27] Misinterpretation and misapplication of biomarkers in inflammatory bowel disease: how do we avoid this?
    Varley, Robert B.
    Lee, James C.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2025, 19 (04) : 359 - 363
  • [28] Stemming the Hype: What Can We Learn from iPSC Models of Parkinson's Disease and How Can We Learn It?
    Jacobs, Benjamin Meir
    JOURNAL OF PARKINSONS DISEASE, 2014, 4 (01) : 15 - 27
  • [29] Can We Change the Past for Colorectal Cancer Patients and How Do We Move Forward?
    Jeon, Justin Y.
    Meyerhardt, Jeffrey A.
    CANCER, 2014, 120 (10) : 1450 - 1452
  • [30] Risk Stratification in Brugada Syndrome: How Low Can We Go?
    Wilde, Arthur A. M.
    Saenen, Johan
    CIRCULATION, 2023, 148 (20) : 1556 - 1558
12345